143 related articles for article (PubMed ID: 26774883)
1. Trends in the Use of (18)F-Fluorodeoxyglucose PET Imaging in Surveillance of Non-Small-Cell Lung and Colorectal Cancer.
Veenstra CM; Vachani A; Ciunci CA; Zafar HM; Epstein AJ; Paulson EC
J Am Coll Radiol; 2016 May; 13(5):491-6. PubMed ID: 26774883
[TBL] [Abstract][Full Text] [Related]
2. Surveillance Practice Patterns after Curative Intent Therapy for Stage I Non-Small-Cell Lung Cancer in the Medicare Population.
Erb CT; Su KW; Soulos PR; Tanoue LT; Gross CP
Lung Cancer; 2016 Sep; 99():200-7. PubMed ID: 27565940
[TBL] [Abstract][Full Text] [Related]
3. Impact of 18F-FDG PET/CT in the treatment of patients with non-small cell lung cancer.
Taus Á; Aguiló R; Curull V; Suárez-Piñera M; Rodríguez-Fuster A; Rodríguez de Dios N; Pijuan L; Zuccarino F; Vollmer I; Sánchez-Font A; Belda-Sanchis J; Arriola E
Arch Bronconeumol; 2014 Mar; 50(3):99-104. PubMed ID: 24360985
[TBL] [Abstract][Full Text] [Related]
4. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
[TBL] [Abstract][Full Text] [Related]
5. [Impact of positron emission tomography on clinical management of potentially resectable non-small-cell lung cancer: a French prospective multicenter study].
Margery J; Milleron B; Vaylet F; Grahek D; Lebeau B; Mangiapan G; Bonardel G; de Labriolle-Vaylet C; Meignan M; Carette MF; Talbot JN; Housset B
Rev Pneumol Clin; 2010 Oct; 66(5):313-20. PubMed ID: 21087727
[TBL] [Abstract][Full Text] [Related]
6. Resected colorectal cancer among Medicare beneficiaries:adoption of FDG PET.
Zafar HM; Mahmoud NN; Mitra N; Wirtalla C; Armstrong K; Groeneveld PW
Radiology; 2010 Feb; 254(2):501-8. PubMed ID: 20093522
[TBL] [Abstract][Full Text] [Related]
7. The effect of FDG-PET on the stage distribution of non-small cell lung cancer.
Morgensztern D; Goodgame B; Baggstrom MQ; Gao F; Govindan R
J Thorac Oncol; 2008 Feb; 3(2):135-9. PubMed ID: 18303433
[TBL] [Abstract][Full Text] [Related]
8. 18F-fluorodeoxyglucose positron emission tomography/computed tomography is useful in postoperative follow-up of asymptomatic non-small-cell lung cancer patients.
Toba H; Sakiyama S; Otsuka H; Kawakami Y; Takizawa H; Kenzaki K; Kondo K; Tangoku A
Interact Cardiovasc Thorac Surg; 2012 Nov; 15(5):859-64. PubMed ID: 22914804
[TBL] [Abstract][Full Text] [Related]
9. Clinical stage I non-small cell lung cancer including FDG-PET Imaging: sites and time to recurrence.
Gauger J; Patz EF; Coleman RE; Herndon JE
J Thorac Oncol; 2007 Jun; 2(6):499-505. PubMed ID: 17545844
[TBL] [Abstract][Full Text] [Related]
10. Impact of Staging With Positron-emission Tomography (PET) and Comorbidities on Management and Survival of American Veterans With Stage I-III Non-Small Cell Lung Cancer.
Raghunathan R; Cease K; Troeschel S; Zhao L; Gross M; Chen G; Chopra V; Ramnath N
Am J Clin Oncol; 2018 May; 41(5):513-518. PubMed ID: 27322696
[TBL] [Abstract][Full Text] [Related]
11. Thoracic staging with
Schaarschmidt BM; Grueneisen J; Metzenmacher M; Gomez B; Gauler T; Roesel C; Heusch P; Ruhlmann V; Umutlu L; Antoch G; Buchbender C
Eur Radiol; 2017 Feb; 27(2):681-688. PubMed ID: 27180186
[TBL] [Abstract][Full Text] [Related]
12. The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation.
Brush J; Boyd K; Chappell F; Crawford F; Dozier M; Fenwick E; Glanville J; McIntosh H; Renehan A; Weller D; Dunlop M
Health Technol Assess; 2011 Sep; 15(35):1-192, iii-iv. PubMed ID: 21958472
[TBL] [Abstract][Full Text] [Related]
13. Thoroughness of mediastinal staging in stage IIIA non-small cell lung cancer.
Vest MT; Tanoue L; Soulos PR; Kim AW; Detterbeck F; Morgensztern D; Gross CP
J Thorac Oncol; 2012 Jan; 7(1):188-95. PubMed ID: 22134069
[TBL] [Abstract][Full Text] [Related]
14. Clinical impact of (18)F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: a prospective study.
Kalff V; Hicks RJ; MacManus MP; Binns DS; McKenzie AF; Ware RE; Hogg A; Ball DL
J Clin Oncol; 2001 Jan; 19(1):111-8. PubMed ID: 11134203
[TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of the 18F-fluorodeoxyglucose positron emission tomography/computed tomography in early-stage nonsmall cell lung cancer.
Geredeli C; Artac M; Kocak I; Koral L; Sakin A; Altinok T; Kaya B; Karaagac M
J Cancer Res Ther; 2020; 16(4):816-821. PubMed ID: 32930124
[TBL] [Abstract][Full Text] [Related]
16. Volume-based parameters of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography improve outcome prediction in early-stage non-small cell lung cancer after surgical resection.
Hyun SH; Choi JY; Kim K; Kim J; Shim YM; Um SW; Kim H; Lee KH; Kim BT
Ann Surg; 2013 Feb; 257(2):364-70. PubMed ID: 22968069
[TBL] [Abstract][Full Text] [Related]
17. Revisiting the prognostic value of preoperative (18)F-fluoro-2-deoxyglucose ( (18)F-FDG) positron emission tomography (PET) in early-stage (I & II) non-small cell lung cancers (NSCLC).
Agarwal M; Brahmanday G; Bajaj SK; Ravikrishnan KP; Wong CY
Eur J Nucl Med Mol Imaging; 2010 Apr; 37(4):691-8. PubMed ID: 19915840
[TBL] [Abstract][Full Text] [Related]
18. 18F-FDG PET/Contrast-Enhanced CT for Initial Staging and Strategic Treatment of Non-Small Cell Lung Cancer: A Prospective Study.
Promteangtrong C; Kunawudhi A; Phadungrerk R; Iamsa-art C; Chotipanich C
J Med Assoc Thai; 2015 Oct; 98(10):1010-8. PubMed ID: 26638593
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Significance of FDG Uptake of Bone Marrow on PET/CT in Patients With Non-Small-Cell Lung Cancer After Curative Surgical Resection.
Lee JW; Na JO; Kang DY; Lee SY; Lee SM
Clin Lung Cancer; 2017 Mar; 18(2):198-206. PubMed ID: 27495385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
